Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Nucl Med ; 34(4): 249-50, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19300062

ABSTRACT

F-18 fluorodeoxyglucose (FDG)-PET-CT is increasingly used in the management of patients with ovarian cancer. However, there is a considerable overlap in the imaging features of malignant and benign ovarian lesions because physiological FDG-uptake in the ovaries can occur, depending on the menstrual cycle in premenopausal women.We present a case of FDG uptake in the ovary co-occurring with an intensely FDG active tumor of the abdominal wall in a 44-year-old woman. PET-CT findings, together with medical history, raised the suspicion for a metastasizing ovarian cancer. However, histologic examination demonstrated benign findings, namely abdominal wall leiomyoma and an ovarian follicular cyst.


Subject(s)
Fluorodeoxyglucose F18/pharmacology , Leiomyoma/diagnostic imaging , Ovarian Neoplasms/diagnostic imaging , Ovary/diagnostic imaging , Adult , Diagnosis, Differential , Diagnostic Imaging , Female , Humans , Leiomyoma/diagnosis , Neoplasm Metastasis , Ovarian Neoplasms/diagnosis , Ovary/pathology , Positron-Emission Tomography/methods , Radiopharmaceuticals/pharmacology , Tomography, X-Ray Computed/methods
2.
J Nucl Med ; 49(3): 354-61, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18287263

ABSTRACT

UNLABELLED: (18)F-FDG PET/CT has gained wide acceptance for evaluation of recurrent colorectal carcinoma. However in clinical practice, contrast-enhanced CT (ceCT) is still the first-line restaging tool. The aim of this study was to investigate the value of contrast-enhanced PET/CT (cePET/CT) as a first-line restaging tool with a special focus on the importance of the use of intravenous contrast. METHODS: Fifty-four patients (17 women, 37 men; mean age, 60.3 y), referred for restaging of colorectal carcinoma, were examined with cePET/CT. Retrospective analysis was performed by 2 experienced readers by consensus: first, ceCT alone; second, non-cePET/CT; and third, cePET/CT. The number, localization, and diagnostic certainty of lesions were evaluated. Additionally, the therapeutic impact of the findings was determined. In 29 patients, histology, clinical imaging, and clinical follow-up served as the reference standard. In 25 patients, clinical follow-up and imaging served as the reference standard. RESULTS: Overall, non-cePET/CT delivered correct additional information to the ceCT findings in 27 of 54 patients (50%). This occurred in (a) 20 of 30 patients, where ceCT was found to be inconclusive, and in (b) 7 of 24 patients with conclusive ceCT findings, where non-cePET/CT found additional lesions, leading to a therapy modification in 5 patients. Compared with non-cePET/CT, cePET/CT revealed additional information in 39 of 54 patients (72%), with therapeutic relevance in 23 patients. This large number was primarily due to correct segmental localization of liver metastases, which is crucial for surgical therapy planning. CONCLUSION: On the basis of its higher accuracy and therapeutic impact compared with ceCT, our data suggest that cePET/CT might be considered as the first-line diagnostic tool for restaging in patients with colorectal cancer.


Subject(s)
Colorectal Neoplasms/diagnosis , Fluorodeoxyglucose F18 , Image Enhancement/methods , Neoplasm Recurrence, Local/diagnosis , Positron-Emission Tomography/methods , Tomography, X-Ray Computed/methods , Contrast Media , Female , Humans , Male , Middle Aged , Neoplasm Staging , Radiopharmaceuticals , Reproducibility of Results , Sensitivity and Specificity
3.
J Magn Reson Imaging ; 25(4): 832-40, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17345633

ABSTRACT

PURPOSE: To evaluate the use of a dynamic keyhole magnetic resonance angiography (MRA) sequence combined with sensitivity encoding (SENSE) for hemodialysis shunts, because surveillance with conventional contrast-enhanced MRA (CE-MRA) is limited by its low temporal resolution, resulting in arteriovenous overlay. MATERIALS AND METHODS: A total of 12 patients with Brescia-Cimino shunts were investigated prospectively using the new technique. During the contrast passage (gadoterate, Gd-DOTA) a series of five to nine dynamic central k-space measurements (10% for upper-arm shunt, 25% for lower-arm shunt) followed by a full reference data set were acquired. The outer k-space data of the single reference scan were used to complete the dynamic data sets. RESULTS: All studies were diagnostic (17 stenoses, three aneurysms) without complications. The acquisition times for a single dynamic scan of the upper- and lower-arm shunts were 2.2 and 3.2 seconds, respectively, while the reference scan needed 13 and 22.4 seconds, respectively. The dynamic angiograms allowed the differentiation of arterial and venous filling despite a mean peak delay time of only 4.2 seconds in the shoulder region. Image quality qualified in consensus by two experienced readers was rated "good" in 19 cases and "intermediate" in five cases with high mean values for signal-to-noise ratios (SNRs) and contrast-to-noise-ratios (CNRs). CONCLUSION: We have successfully implemented a fast, dynamic, CE-MRA technique with CE timing robust angiography (CENTRA) keyhole and SENSE in clinical routine. High spatial and temporal resolution improve the diagnostics of dialysis shunts and allow the assessment of detailed, dynamic, four-dimensional (4D) information.


Subject(s)
Arteriovenous Shunt, Surgical , Graft Occlusion, Vascular/diagnosis , Magnetic Resonance Angiography/methods , Renal Dialysis , Adult , Aged , Arm , Contrast Media , Female , Heterocyclic Compounds , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Organometallic Compounds , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...